Did smokefree legislation in England reduce exposure to secondhand smoke among nonsmoking adults? Cotinine analysis from the Health Survey for England

Michelle Sims, Jennifer S Mindell, Martin J Jarvis, Colin Feyerabend, Heather Wardle, Anna Gilmore, Michelle Sims, Jennifer S Mindell, Martin J Jarvis, Colin Feyerabend, Heather Wardle, Anna Gilmore

Abstract

Background: On 1 July 2007, smokefree legislation was implemented in England, which made virtually all enclosed public places and workplaces smokefree.

Objectives: We examined trends in and predictors of secondhand smoke exposure among nonsmoking adults to determine whether exposure changed after the introduction of smokefree legislation and whether these changes varied by socioeconomic status (SES) and by household smoking status.

Methods: We analyzed salivary cotinine data from the Health Survey for England that were collected in 7 of 11 annual surveys undertaken between 1998 and 2008. We conducted multivariate regression analyses to examine secondhand smoke exposure as measured by the proportion of nonsmokers with undetectable levels of cotinine and by geometric mean cotinine.

Results: Secondhand smoke exposure was higher among those exposed at home and among lower-SES groups. Exposure declined markedly from 1998 to 2008 (the proportion of participants with undetectable cotinine was 2.9 times higher in the last 6 months of 2008 compared with the first 6 months of 1998 and geometric mean cotinine declined by 80%). We observed a significant fall in exposure after legislation was introduced--the odds of having undetectable cotinine were 1.5 times higher [95% confidence interval (CI): 1.3, 1.8] and geometric mean cotinine fell by 27% (95% CI: 17%, 36%) after adjusting for the prelegislative trend and potential confounders. Significant reductions were not, however, seen in those living in lower-social class households or homes where smoking occurs inside on most days.

Conclusions: We found that the impact of England's smokefree legislation on secondhand smoke exposure was above and beyond the underlying long-term decline in secondhand smoke exposure and demonstrates the positive effect of the legislation. Nevertheless, some population subgroups appear not to have benefitted significantly from the legislation. This finding suggests that these groups should receive more support to reduce their exposure.

Conflict of interest statement

The authors declare they have no actual or potential competing financial interests.

Figures

Figure 1
Figure 1
Trends in SHS exposure in nonsmoking adults in England from 1998 to 2008 in 6-month time periods using the proportion with undetectable cotinine (A), and geometric mean cotinine (B). Error bars indicate 95% CIs. SFL (smokefree legislation) shows the date when legislation was implemented.
Figure 2
Figure 2
Trends in SHS exposure among nonsmoking adults in England from 1998 to 2008 in 6-month time periods by household smoking status (A and B) and social class of head of household (C and D) using proportion with undetectable cotinine (A and C), geometric mean cotinine (B and D). Error bars indicate 95% CIs. SFL (smokefree legislation) indicates when the legislation was implemented.

References

    1. Adda J, Cornaglia F. The effect of bans and taxes on passive smoking. Am Econ J Appl Econ. 2010;2(1):1–32.
    1. Barone-Adesi F, Gasparrini A, Vizzini L, Merletti F, Richiardi L.2011Effects of Italian smoking regulation on rates of hospital admission for acute coronary events: a country- wide study. PLoS ONE 6e17419; doi: [Online 2 March 2011]10.1371/journal.pone.0017419
    1. Bauer U, Juster H, Hyland A, Farrelly M, Engelen M, Weitzenkamp D, et al. Reduced Secondhand Smoke Exposure After Implementation of a Comprehensive Statewide Smoking Ban—New York, June 26, 2003 June 30, 2004. MMWR Morb Mortal Wkly Rep. 2007;56(28):705–708.
    1. Benowitz NL. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev. 1996;18(2):188–204.
    1. Bernert JT, Jacob P, III, Holiday DB, Benowitz NL, Sosnoff CS, Doig MV, et al. Interlaboratory comparability of serum cotinine measurements at smoker and nonsmoker concentration levels: a round-robin study. Nicotine Tob Res. 2009;11(12):1458–1466.
    1. California Environmental Protection Agency. Sacramento, CA: Office of Environmental Health Hazard Assessment, California Environmental Protection Agency; 2005. Proposed Identification of Environmental Tobacco Smoke as a Toxic Air Contaminant. Part B: Health Effects. Final Report, June 2005.
    1. Chan-Yeung M, Dimich-Ward H. Respiratory health effects of exposure to environmental tobacco smoke. Respirology. 2003;8(2):131–139.
    1. Craig R, Mindell J, Hirani V, eds. Leeds: NHS Information Centre; 2009. Health Survey for England 2008. Volume 2—Methods and Documentation.
    1. Department of Health Statistics on smoking: England, 1978 onwards. Stat Bull. 2000;17:1–36.
    1. Department of Health. Smokefree England—one year on. 2008. Available: [accessed 7 February 2012]
    1. Department of Health. Health Survey for England. Health Survey Background. 2010. Available: [accessed 29 July 2010]
    1. Ellis JA, Gwynn C, Garg RK, Philburn R, Aldous KM, Perl SB, et al. Secondhand smoke exposure among nonsmokers nationally and in New York City. Nicotine Tob Res. 2009;11(4):362–370.
    1. Evans K. Bath, UK: University of Bath, 84; 2010. Trends and determinants of people’s knowledge of the illnesses caused by secondhand smoke (SHS), and the relationship between knowledge and SHS-related behaviours [Abstract]. In: 12th Annual Conference SRNT Europe: Translating Science to Policy. 6–9 September 2010, Bath, UK.
    1. Feyerabend C, Russell MA. A rapid gas-liquid chromatographic method for the determination of cotinine and nicotine in biological fluids. J Pharm Pharmacol. 1990;42(6):450–452.
    1. Haw SJ, Gruer L.2007Changes in exposure of adult nonsmokers to secondhand smoke after implementation of smoke-free legislation in Scotland: national cross sectional survey. BMJ 3357619549; doi: [Online 13 September 2007]10.1136/bmj.39315.670208.47
    1. Hecht SS, Ye M, Carmella SG, Fredrickson A, Adgate JL, Greaves IA, et al. Metabolites of a tobacco-specific lung carcinogen in the urine of elementary school-aged children. Cancer Epidemiol Biomarkers Prev. 2001;10(11):1109–1116.
    1. Helsel D. Much ado about next to nothing: incorporating nondetects in science. Ann Occup Hyg. 2010;54(3):257–262.
    1. Hewett P, Ganser GH. A comparison of several methods for analyzing censored data. Ann Occup Hyg. 2007;51(7):611–632.
    1. IARC (International Agency for Research on Cancer) Lyon, France: IARC, 135–162; 2009. Reductions in exposure to secondhand smoke and effects on health due to restrictions on smoking. In: IARC Handbooks of Cancer Prevention. Tobacco Control: Evaluating the Effectiveness of Smoke-free Policies, Vol 13.
    1. Jarvis MJ, Feyerabend C, Bryant A, Hedges B, Primatesta P. Passive smoking in the home: plasma cotinine concentrations in nonsmokers with smoking partners. Tob Control. 2001;10(4):368–374.
    1. Jarvis MJ, Fidler J, Mindell J, Feyerabend C, West RJ. Assessing smoking status in children, adolescents, and adults: cotinine cut-points revisited. Addiction. 2008;103(9):1553–1561.
    1. Jarvis MJ, Mindell J, Gilmore A, Feyerabend C, West R. Smoke-free homes in England: prevalence, trends, and validation by cotinine in children. Tob Control. 2009;18(6):491–495.
    1. Jarvis M, Tunstall-Pedoe H, Feyerabend C, Vesey C, Salloojee Y. Biochemical markers of smoke absorption and self reported exposure to passive smoking. J Epidemiol Community Health. 1984;38(4):335–339.
    1. Juster HR, Loomis BR, Hinman TM, Farrelly MC, Hyland A, Bauer UE, et al. Declines in hospital admissions for acute myocardial infarction in New York state after implementation of a comprehensive smoking ban. Am J Public Health. 2007;97(11):2035–2039.
    1. Mindell J, Aresu M, Bécares L, Tolonen H.2011Representativeness of participants in a cross-sectional health survey by time of day and day of week of data collection. Eur J Public Health 16; doi:10.1093/eurpub/ckr093[Online 29 September 2011]
    1. Naiman A, Glazier RH, Moineddin R. Association of antismoking legislation with rates of hospital admission for cardiovascular and respiratory conditions. CMAJ. 2010;182(8):761–767.
    1. NHS Information Centre. Health Survery for England. 2010a. Available: [accessed 25 August 2010]
    1. NHS Information Centre. Statistics on Smoking: England, 2010. 2010b. Available: [accessed 25 August 2010]
    1. Office of Population Censuses and Surveys. London: Her Majesty’s Stationery Office; 1991. Standard Occupational Classification, Vol 3.
    1. Pirkle J, Bernert JT, Caudill SP, Sosnoff CS, Pechacek TF. Trends in the exposure of nonsmokers in the U.S. population to secondhand smoke:1988–2002. Environ Health Perspect. 2006;114:853–858.
    1. Royal College of Physicians. London: RCP; 2005. Going smoke-free: the medical case for clean air in the home, at work and in public places. (A report by the Tobacco Advisory Group of the Royal College of Physicians)
    1. Sims M, Maxwell R, Bauld L, Gilmore A.2010aShort-term impact of smokefree legislation in England: retrospective analysis of hospital admissions for myocardial infarction. BMJ 340c2161; doi:10.1136/bmj.c2161[Online 8 June 2010]
    1. Sims M, Tomkins S, Judge K, Taylor G, Jarvis MJ, Gilmore A. Trends in and predictors of secondhand smoke exposure indexed by cotinine in children in England from 1996 to 2006. Addiction. 2010b;105(3):543–553.
    1. U.S. Department of Health and Human Services, Office of the Surgeon General. The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General. 2006. Available: [accessed 16 June 2011]
    1. Whincup PH, Gilg JA, Emberson JR, Jarvis MJ, Feyerabend C, Bryant A, et al. Passive smoking and risk of coronary heart disease and stroke: prospective study with cotinine measurement. BMJ. 2004;329(7459):200–205.
    1. Zocchetti C, Consonni D, Bertazzi PA. Relationship between prevalence rate ratios and odds ratios in cross-sectional studies. Int J Epidemiol. 1997;26(1):220–223.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться